// App-Quantinova.ai

e22018 : Comparison of microfilter-based capture to CellSearch in detection of circulating tumor cells (CTCs) in patients with metastatic castration-resistant prostate cancer (mCRPCa).

Researchers

Presenter

  • Christos Kyriakopoulos

Principal Investigators

  • Paul Elson

  • Siddarth Rawal

  • Ram H Datar

  • Richard J. Cote

  • Jorge A. Garcia

  • Ernest C. Borden

  • Anthony Williams

  • Zheng Ao

Medical Centers

  • Cleveland Clinic Foundation-Department of Translational Hematology and Oncology Research, Cleveland, OH

  • University of Washington, Seattle, WACleveland Clinic, Cleveland, OHCleveland Clinic Foundation, Cleveland, OH

  • Taussig Cancer Institute Cleveland Clinic, Cleveland, OH

  • University of Miami Miller School of Medicine, Miami, FL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • Circulating tumor cells

  • Cluster of differentiation 45

  • Translocator protein

Drug/Treatment

  • N/A

Outcome

  • Positive


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final